Search

Your search keyword '"Stadler, Michael"' showing total 90 results

Search Constraints

Start Over You searched for: Author "Stadler, Michael" Remove constraint Author: "Stadler, Michael" Publisher elsevier bv Remove constraint Publisher: elsevier bv
90 results on '"Stadler, Michael"'

Search Results

1. Towards stratified treatment of JIA: machine learning identifies subtypes in response to methotrexate from four UK cohorts

2. Localization of the Drosophila pioneer factor GAF to subnuclear foci is driven by DNA binding and required to silence satellite repeat expression

3. Convergence of multiple RNA-silencing pathways on GW182/TNRC6

4. Clinical Impact and Accuracy of Shave Biopsy for Initial Diagnosis of Cutaneous Melanoma

6. Multimodal characterization of murine gastruloid development

7. N-acetylcysteine overcomes NF1 loss-driven resistance to PI3Kα inhibition in breast cancer

8. Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia

9. A phase 2 trial of a topical antiseptic bundle in head and neck cancer surgery: Effects on surgical site infection and the oral microbiome

18. Cell Types of the Human Retina and Its Organoids at Single-Cell Resolution

20. Intermediate-grade carcinoma of the parotid and the impact of adjuvant radiation

22. Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party

23. Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland

25. Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3

26. Cell Types of the Human Retina and Its Organoids at Single-Cell Resolution: Developmental Convergence, Transcriptomic Identity, and Disease Map

28. Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trial

30. Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with acute myeloid leukemia with normal karyotype

32. Possible Impact of Cytomegalovirus-Specific CD8+ T Cells on Immune Reconstitution and Conversion to Complete Donor Chimerism after Allogeneic Stem Cell Transplantation

33. Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation

34. An Immune Atlas of Clear Cell Renal Cell Carcinoma

35. Safety and Efficacy of Donor T Cells Engineered with Herpes Simplex Virus Thymidine-Kinase Suicide Gene (TK Cells) Given after T-Cell Depleted (TCD) Haploidentical Hematopoietic Transplantation (Haplo-HSCT): Results of a 14-Year Follow-Up in 45 Patients

49. Treatment of Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Stem Cell Transplantation with Azacitidine and Donor Lymphocyte Infusions—A Retrospective Multicenter Analysis from the German Cooperative Transplant Study Group

Catalog

Books, media, physical & digital resources